ISSN 0975-3583
 

Journal of Cardiovascular Disease Research

2021, Vol: 8, Issue: 8
Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles
Required files to be uploaded

Copyright


    Safety and efficacy of combination of vilanterol and Fluticasone furoate (once daily) in comparison to Salmetrol/fluticasone propionate (twice daily) in bronchial asthma


    Dr. Kunal Sahai, Dr. Devopam Roy, Dr. Deepak Gupta
    JCDR. 2023: 4046-4049

    Abstract

    The treatment of persistent asthma has been aided by the recent approval of new medications. Vilanterol (Ultra long-acting β2 Agonist) is one of these new agents, which was recently approved as a maintenance therapy for persistent asthma. This once-daily ICS/ vilanterol inhaler has previously been approved and used in chronic obstructive pulmonary disease as a maintenance therapy. Both FF and VI individually have been shown to have efficacy in the treatment of persistent asthma and COPD; the combination of FF/VI at the dose of 100/25 μg daily improves trough peak expiratory flows and forced expiratory volume in 1s. It also reduces the frequency of asthma exacerbations in patients with persistent asthma

    Description

    .

    » PDF

    Volume & Issue

    Volume 14 Issue 1

    Keywords

    .
Submit Article
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.
The articles in Journal of Cardiovascular Disease Research are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Copyright � 2022 Journal of Cardiovascular Disease Research All Rights Reserved. Subject to change without notice from or liability to Journal of Cardiovascular Disease Research. For best results, please use Internet Explorer or Google Chrome


POLICIES & JOURNAL LINKS

Contact Information


Journal of cardiovascular Disease Research,
No: 763-1/A Gandhi Road-2 Vimal Guptha Residency, Nauroji Nagar- New Delhi 110029

Phone : 0975-3583, 0976-2833

editor@jcdronline.org